Taysha Gene Therapies, Inc.TSHANASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-91.46M
Near historical average
Average (5y)
$-84.55M
Historical baseline
Range
High:$-1.11M
Low:$-173.27M
CAGR
+141.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-91.46M | -26.3% |
| 2023 | $-72.44M | +42.5% |
| 2022 | $-126.03M | +27.3% |
| 2021 | $-173.27M | -302.9% |
| 2020 | $-43.00M | -3756.7% |
| 2019 | $-1.11M | - |